Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes.

Sharma, Sameer; Misra, Chandra Sekhar; Arumugam, Surendar; Roy, Subhasis; Shah, Vanya; Davis, Joseph Alex; Shirumalla, Raj Kumar; Ray, Abhijit

Sharma, Sameer; Misra, Chandra Sekhar; Arumugam, Surendar; Roy, Subhasis; Shah, Vanya; Davis, Joseph Alex; Shirumalla, Raj Kumar; Ray, Abhijit.

Affiliation

Sharma S; Department of Pharmacology, New Drug Discovery Research, Ranbaxy Research Laboratories, Gurgaon, Haryana, India. sameer.sharma@ranbaxy.com

Phytother Res ; 25(1): 67-73, 2011 Jan.

Article in En | MEDLINE | ID: mdl-20623590

Subject(s)

Diabetes Mellitus, Type 2/enzymology; Enzyme Activation/drug effects; Hypoglycemic Agents/pharmacology; Sirtuin 1/metabolism; Stilbenes/pharmacology; Adiponectin/blood; Animals; Body Weight/drug effects; Chemotherapy, Adjuvant; Cholesterol/blood; Diabetes Mellitus, Type 2/genetics; Fatty Acids, Nonesterified/blood; Glucose/pharmacology; Glucose Tolerance Test; Insulin/blood; Mice; Resveratrol; Triglycerides/blood

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Stilbenes / Diabetes Mellitus, Type 2 / Enzyme Activation / Sirtuin 1 / Hypoglycemic Agents Type of study: Prognostic_studies Language: En Journal: Phytother Res Year: 2011 Type: Article Affiliation country: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google